UnitedHealth Group Incorporated (NYSE: UNH) receives reaffirmed Buy rating from Bernstein with a price target of $379, citing strong short-term potential and solid long-term value. UBS also maintains Buy rating and $378 price target, optimistic about the company’s reaffirmation of 2025 guidance. Analysts estimate an average price target of $325 for UNH, implying a downside of nearly 5.88% from current levels. UnitedHealth is a leading U.S. healthcare company operating through four segments. While UNH shows investment potential, some AI stocks may offer greater upside with less downside risk.

Read more at Yahoo Finance: Bernstein Reaffirms Buy Rating on UnitedHealth Group, Keeps PT at $379